Showing results (171-180 of 212) with videos related to
Sort By:
Pageof 22
Genome Medicine|July 6, 2012
Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerabilityMichael J Demeure, David W Craig, Shripad Sinari, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid TumorsDaniel D Von Hoff, Monica M Mita, Ramesh K Ramanathan, et al.Plos One|June 1, 2012
Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastomaGlen J Weiss, Winnie S Liang, Tyler Izatt, et al.JAMA Oncology|May 24, 2019
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical TrialThomas B Karasic, Mark H O'Hara, Arturo Loaiza-Bonilla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trialDaniel D Von Hoff, Ramesh K Ramanathan, Mitesh J Borad, et al.JAMA Oncology|October 4, 2019
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical TrialGayle S Jameson, Erkut Borazanci, Hani M Babiker, et al.Redox Biology|November 6, 2025
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancerGayle S Jameson, S Danielle LeGrand, Michael S Gordon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancersDaniel D Von Hoff, Joseph J Stephenson, Peter Rosen, et al.British Journal of Cancer|December 21, 2019
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinomaAna De Jesus-Acosta, Elizabeth A Sugar, Peter J O'Dwyer, et al.Plos One|November 9, 2013
A pilot study using next-generation sequencing in advanced cancers: feasibility and challengesGlen J Weiss, Winnie S Liang, Michael J Demeure, et al.Pageof 22